Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Targeting persisters for tuberculosis control.

Antimicrobial agents and chemotherapy - 1 May 2012

Zhang Ying, Yew Wing Wai, Barer Michael R

Abstract excerpt

Mycobacterial persisters, the survivors from antibiotic exposure, necessitate the lengthy treatment of tuberculosis (TB) and pose a significant challenge for our control of the disease. We suggest that persisters in TB are heterogeneous in nature and comprise various proportions of the population depending on the circumstances; the mechanisms of their formation are complex and may be related to those required for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antitubercular Agents
Share to Energy Metabolism
Share to Host-Pathogen Interactions

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Molecular Targeted Therapy

Share to Mycobacterium tuberculosis

Share to Proteasome Endopeptidase Complex

Share to Proteolysis

Share to Tuberculosis, Pulmonary

Source

Open in PubMed Open full text

Identifiers

PMID: 22391538
DOI: 10.1128/AAC.06288-11
PMCID: PMC3346619

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Targeting persisters for tuberculosis control.PMID 22391538Read ↗

Insights into the molecular determinants involved in Mycobacterium tuberculosis persistence and their therapeutic implicationsSemantic proximity Read ↗

High Persister Mutants in Mycobacterium tuberculosis.Semantic proximity Read ↗

Role of persister cells in chronic infections: clinical relevance and perspectives on anti-persister therapiesSemantic proximity Read ↗

Molecular mechanisms and clinical implications of bacterial persistence.Semantic proximity Read ↗

Multiple Toxin-Antitoxin Systems in Mycobacterium tuberculosisSemantic proximity Read ↗

Noise in a Metabolic Pathway Leads to Persister Formation in Mycobacterium tuberculosisSemantic proximity Read ↗

Dual-Reporter Mycobacteriophages (Φ 2 DRMs) Reveal Preexisting Mycobacterium tuberculosis Persistent Cells in Human SputumSemantic proximity Read ↗

Phenotypic adaptation of Mycobacterium tuberculosis to host-associated stressors that induce persister formationSemantic proximity Read ↗

Mycobacterial biofilms: A therapeutic target against bacterial persistence and generation of antibiotic resistanceSemantic proximity Read ↗

New-found fundamentals of bacterial persistence.Semantic proximity Read ↗

Central carbon metabolism remodeling as a mechanism to develop drug tolerance and drug resistance in Mycobacterium tuberculosisSemantic proximity Read ↗

Fighting bacterial persistence: Current and emerging anti-persister strategies and therapeutics.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.